Transvenous Phrenic Nerve Stimulation for Heart Failure Patients with Central Sleep Apnea

2024-09-30T20:31:54-07:00

When heart failure and sleep apnea collide, the search for effective treatment becomes even more pressing. Patients grappling with both conditions often face complex health challenges, making innovative solutions essential.  Transvenous phrenic nerve stimulation, FDA approved in October 2017, provides a breakthrough approach, specifically designed

Transvenous Phrenic Nerve Stimulation for Heart Failure Patients with Central Sleep Apnea2024-09-30T20:31:54-07:00

Study Shows: Remedē Maintains Safety and Effectiveness Over 5 Years

2024-07-18T06:12:36-07:00

A recent five-year study on the Remedē System has shown promising results confirming that this innovative implant maintains safety and effectiveness over an extended period. This comprehensive research offers hope and reassurance to patients and healthcare providers alike. Demonstrating that the Remedē System improves sleep

Study Shows: Remedē Maintains Safety and Effectiveness Over 5 Years2024-07-18T06:12:36-07:00